4.7 Article

The impact of young age on cancer-specific and non-cancer-related survival after surgery for colorectal cancer: 10-year follow-up

Journal

BRITISH JOURNAL OF CANCER
Volume 101, Issue 4, Pages 557-560

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6605222

Keywords

colorectal cancer; age; elective; curative surgery; survival

Categories

Funding

  1. Clinical Resource and Audit Group (CRAG)
  2. Chief Scientist Office
  3. Scottish Home and Health Department, Scotland

Ask authors/readers for more resources

BACKGROUND: It has been reported that although young patients present with more advanced disease, when adjusted for stage, cancer-specific survival is not different after surgery for colorectal cancer. However, few studies have examined non-cancer survival in young patients and 10-year survival has rarely been reported. Moreover, the largest study included patients of old age as a comparator. The aim of this study was to compare cancer-specific and non-cancer-related survival at 10 years in a young age cohort and a middle age cohort in patients undergoing surgery for colorectal cancer. METHODS: Two thousand and seventy seven patients who underwent surgery for colorectal cancer between 1991 and 1994 in 11 hospitals in Scotland were included in the study. Ten-year cancer-specific and non-cancer-related survival and the hazard ratios (HR) were calculated according to age groups (< 45/45-54/55-64/65-74 years). RESULTS: On follow-up, 1066 patients died of their cancer and 369 died of non-cancer-related causes. At 10 years, overall survival was 32%, cancer-specific was 45%, and non-cancer-related survival was 72%. On multivariate analysis of all factors, sex (HR 0.77, 95% CI 0.68-0.88, P < 0.001), mode of presentation (HR 1.64, 95% CI 1.44-1.87, P < 0.01), Dukes' stage (HR 2.69, 95% CI 2.49-2.90, P < 0.001), and specialisation (HR 1.24, 95% CI 1.04-1.44, P < 0.01) were independently associated with cancer-specific survival. On multivariate analysis of all factors, age (HR 2.46, 2.04-2.97, P < 0.001), sex (HR 0.56, 0.45-0.70, P < 0.001), and deprivation (HR 1.16, 1.10-1.24, P < 0.001) were independently associated with non-cancer-related survival. CONCLUSION: The results of this study confirm that young age does not have a negative impact on cancer-specific survival. Moreover, they show that, with 10-year follow-up, young age does not have a negative impact on non-cancer-related survival. British Journal of Cancer (2009) 101, 557-560. doi: 10.1038/sj.bjc.6605222 www.bjcancer.com (C) 2009 Cancer Research UK

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Nutrition & Dietetics

The relation between Malnutrition Universal Screening Tool (MUST), computed tomography-derived body composition, systemic inflammation, and clinical outcomes in patients undergoing surgery for colorectal cancer

Arwa S. Almasaudi, Stephen T. McSorley, Ross D. Dolan, Christine A. Edwards, Donald C. McMillan

AMERICAN JOURNAL OF CLINICAL NUTRITION (2019)

Review Oncology

The local inflammatory response in colorectal cancer - Type, location or density? A systematic review and meta-analysis

Peter G. Alexander, Donald C. McMillan, James H. Park

CANCER TREATMENT REVIEWS (2020)

Article Oncology

Determinants of quality of life in patients with incurable cancer

Louise E. Daly, Ross D. Dolan, Derek G. Power, Eadaoin Ni Bhuachalla, Wei Sim, Samantha J. Cushen, Marie Fallon, Claribel Simmons, Donald C. Mcmillan, Barry J. Laird, Aoife M. Ryan

CANCER (2020)

Review Oncology

The prevalence of cancer associated systemic inflammation: Implications of prognostic studies using the Glasgow Prognostic Score

Ross D. Dolan, Donald C. McMillan

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)

Article Multidisciplinary Sciences

A comparison of the prognostic value of composite ratios and cumulative scores in patients with operable rectal cancer

Ross D. Dolan, Muhammed Alwahid, Stephen T. McSorley, James H. Park, Richard P. Stevenson, Campbell S. Roxburgh, Paul G. Horgan, Donald C. McMillan

SCIENTIFIC REPORTS (2020)

Article Oncology

The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer

Peter G. Alexander, Antonia K. Roseweir, Kathryn A. F. Pennel, Hester C. van Wyk, Arfon G. M. T. Powell, Donald C. McMillan, Paul G. Horgan, Caroline Kelly, Jennifer Hay, Owen Sansom, Andrea Harkin, Campbell S. D. Roxburgh, Janet Graham, David N. Church, Ian Tomlinson, Mark Saunders, Tim J. Iveson, Joanne Edwards, James H. Park

Summary: The Glasgow Microenvironment Score (GMS) is validated as a prognostic tool for patients with stage I-III colorectal cancer, independent of TNM staging, and has the ability to stratify both low- and high-risk disease. Additionally, GMS 0 can be used to identify patients who benefit from FOLFOX over CAPOX chemotherapy.

BRITISH JOURNAL OF CANCER (2021)

Article Oncology

Vascular calcification and response to neoadjuvant therapy in locally advanced rectal cancer: an exploratory study

Katrina A. Knight, Ioanna Drami, Donald C. McMillan, Paul G. Horgan, James H. Park, John T. Jenkins, Campbell S. D. Roxburgh

Summary: The study found that calcification of the aortoiliac vessels supplying the rectum (AC) was not associated with NACRT response in the examined cohorts. Larger contemporary cohorts are needed to better assess host determinants of NACRT response and develop predictive models to improve patient selection.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Oncology

The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: an analysis of 1700 patients

Allan M. Golder, Donald C. McMillan, James H. Park, David Mansouri, Paul G. Horgan, Campbell S. Roxburgh

Summary: This study demonstrates that the pre-operative systemic inflammatory response (SIR) in patients undergoing curative surgery for colon cancer is best evaluated using a Systemic Inflammatory Grade (SIG) combining modified Glasgow Prognostic Score (mGPS) and neutrophil-lymphocyte ratio (NLR). Both mGPS and NLR have a significant impact on survival rates in colon cancer patients, and their combined use can better predict outcomes.

BRITISH JOURNAL OF CANCER (2021)

Article Nutrition & Dietetics

Relation Between Body Composition, Systemic Inflammatory Response, and Clinical Outcomes in Patients Admitted to an Urban Teaching Hospital with COVID-19

Josh McGovern, Ross Dolan, Conor Richards, Barry J. Laird, Donald C. McMillan, Donogh Maguire

Summary: The study found that sarcopenia in the presence of obesity was associated with higher 30-day mortality in patients with COVID-19.

JOURNAL OF NUTRITION (2021)

Article Oncology

Cancer cachexia: a nutritional or a systemic inflammatory syndrome?

Josh McGovern, Ross D. Dolan, Richard J. Skipworth, Barry J. Laird, Donald C. McMillan

Summary: Cancer cachexia has traditionally been viewed as a nutritional syndrome, but recent research suggests that it may be primarily a manifestation of systemic inflammation. This has important implications for future treatment strategies.

BRITISH JOURNAL OF CANCER (2022)

Article Cell Biology

The Relationship Between the Tumor Cell Expression of Hypoxic Markers and Survival in Patients With ER-positive Invasive Ductal Breast Cancer

Suad A. K. Shamis, Jean Quinn, Elizabeth E. A. Mallon, Joanne Edwards, Donald C. McMillan

Summary: The prognostic significance of hypoxia markers in estrogen receptor-positive breast cancer patients was investigated. The expression of these markers was associated with clinicopathological parameters and disease-free survival.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2022)

Article Oncology

The Glasgow Microenvironment Score and risk and site of recurrence in TNM I-III colorectal cancer

P. G. Alexander, H. C. van Wyk, K. A. F. Pennel, J. Hay, D. C. McMillan, P. G. Horgan, C. S. D. Roxburgh, J. Edwards, J. H. Park

Summary: The Glasgow Microenvironment Score (GMS) is associated with the location of recurrence in colorectal cancer. Higher GMS categories (GMS 1 and 2) are associated with an increased risk of local and distant recurrence.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Lactate dehydrogenase: relationship with the diagnostic GLIM criterion for cachexia in patients with advanced cancer

Josh McGovern, Ross D. Dolan, Claribel P. L. Simmons, Louise E. Daly, Aoife M. Ryan, Derek G. Power, Donogh Maguire, Marie T. Fallon, Barry J. Laird, Donald C. McMillan

Summary: This study found a relationship between serum LDH level, phenotypic/aetiologic diagnostic GLIM criteria, and survival in patients with advanced cancer.

BRITISH JOURNAL OF CANCER (2023)

Article Health Care Sciences & Services

Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer

Bruna M. M. Rocha, Ross D. Dolan, Carlos E. Paiva, Josh McGovern, Bianca S. R. Paiva, Daniel D. Preto, Donald C. McMillan, Yara C. P. Maia, Barry J. Laird

Summary: This study compares prognostic factors in two international cohorts of patients with advanced cancer and establishes a prognostic framework for treatment. The study finds that despite geographical and socio-demographic differences, similar prognostic factors are associated with long-term survival in both the European and Brazilian cohorts.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2023)

Review Oncology

The effect of postoperative complications on survival and recurrence after surgery for breast cancer: A systematic review and meta-analysis

F. Savioli, J. Edwards, D. McMillan, S. Stallard, J. Doughty, L. Romics

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)

No Data Available